Literature DB >> 29389238

Inflammatory Diseases of the Gut.

Michael Rohr1, Chandrakala Aluganti Narasimhulu1, Dhara Sharma1, Mitsushita Doomra1, Aladdin Riad1, Saleh Naser1, Sampath Parthasarathy1.   

Abstract

Inflammatory bowel diseases (IBD), including Crohn's disease and ulcerative colitis, are chronic inflammatory disorders of the gastrointestinal tract whose prevalence has been dramatically increasing over the past decade. New studies have shown that IBD is the second most common chronic inflammatory disease worldwide after rheumatoid arthritis, affecting millions of people mainly in industrialized countries. Symptoms of IBD include frequent bloody diarrhea, abdominal cramping, anorexia, abdominal distension, and emesis. Although the exact etiology is unknown, it has been postulated that immunological, microbial, environmental, nutritional, and genetic factors contribute to the pathogenesis and severity of IBD. Today, no treatment has consistently been shown to be successful in treating IBD. This review summarizes current research on the epidemiology, etiology, pathophysiology, and existing treatment approaches, including pharmaceutical and nutritional options for IBD.

Entities:  

Keywords:  Crohn's disease; inflammation; microbiome; ulcerative colitis

Mesh:

Year:  2018        PMID: 29389238     DOI: 10.1089/jmf.2017.0138

Source DB:  PubMed          Journal:  J Med Food        ISSN: 1096-620X            Impact factor:   2.786


  5 in total

1.  MiR-146a rs2910164 G > C polymorphism modulates Notch-1/IL-6 signaling during infection: a possible risk factor for Crohn's disease.

Authors:  Esra'a Keewan; Saleh A Naser
Journal:  Gut Pathog       Date:  2020-10-15       Impact factor: 4.181

2.  Gut Mucosal Microbiome Is Perturbed in Rheumatoid Arthritis Mice and Partly Restored after TDAG8 Deficiency or Suppression by Salicylanilide Derivative.

Authors:  Ngoc Tuan Nguyen; Wei-Hsin Sun; Tzu-Hsuan Chen; Po-Chun Tsai; Chih-Chen Chen; Shir-Ly Huang
Journal:  Int J Mol Sci       Date:  2022-03-24       Impact factor: 5.923

Review 3.  Probiotics in Autoimmune and Inflammatory Disorders.

Authors:  Yuying Liu; Jane J Alookaran; J Marc Rhoads
Journal:  Nutrients       Date:  2018-10-18       Impact factor: 5.717

4.  Remission in Crohn's disease is accompanied by alterations in the gut microbiota and mucins production.

Authors:  Daniéla Oliveira Magro; Andrey Santos; Dioze Guadagnini; Flavia Moreira de Godoy; Sylvia Helena Monteiro Silva; Wilson José Fernandes Lemos; Nicola Vitulo; Sandra Torriani; Lilian Vital Pinheiro; Carlos Augusto Real Martinez; Mario José Abdalla Saad; Claudio Saddy Rodrigues Coy
Journal:  Sci Rep       Date:  2019-09-13       Impact factor: 4.379

5.  Inhibitory Effects of the Lactobacillus rhamnosus GG Effector Protein HM0539 on Inflammatory Response Through the TLR4/MyD88/NF-кB Axis.

Authors:  Yubin Li; Shaojie Yang; Jingxian Lun; Jie Gao; Xuefeng Gao; Zelong Gong; Yu Wan; Xiaolong He; Hong Cao
Journal:  Front Immunol       Date:  2020-10-05       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.